Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. - Wikidata - awgldk - TriplyDB

Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

http://www.wikidata.org/entity/Q34775968

about

Microbial translocation in chronic liver diseases Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity Role of liver transplantation in human immunodeficiency virus positive patients Markers of bacterial translocation in end-stage liver disease Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin trea The impact of social factors on human immunodeficiency virus and hepatitis C virus co-infection in a minority region of Si-chuan, the People's Republic of China: a population-based survey and testing study Sero-prevalence of hepatitis B virus and hepatitis C virus among HIV patients in a suburban University Teaching Hospital in South-East Nigeria Human immunodeficiency virus and liver disease forum 2010: conference proceedings Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections.Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection Systemic effects of inflammation on health during chronic HIV infection Cellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patients Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.Bacterial oncogenesis in the colon Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals.Hepatic fibrosis.Molecular mechanisms of liver fibrosis in HIV/HCV coinfection Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART Alcohol and HIV disease progression: weighing the evidence Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.Mechanisms underlying γδ T-cell subset perturbations in SIV-infected Asian rhesus macaques.Detection of microbial translocation in HIV and SIV infection using the Limulus amebocyte lysate assay is masked by serum and plasma.Anatomical localization of commensal bacteria in immune cell homeostasis and disease The dormant blood microbiome in chronic, inflammatory diseases.HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection Microbial translocation: a marker of advanced HIV-1 infection and a predictor of treatment failure?HBV and HIV co-infection: Impact on liver pathobiology and therapeutic approaches.

P2860

Q21284997-2E5887C5-1BD8-4B4B-A45E-8D23A9543462 Q26773267-C4C197DB-87FE-4B60-95EB-C4194785B23C Q26775931-83023278-A364-4736-A360-C1442771F63C Q26783888-41BA79F3-76C1-426C-A034-31950195A548 Q26798469-D225EF2B-EAFD-4885-943F-E7EE844F3FDF Q26991549-61CDBCBC-2534-4561-B185-A5014AB1E145 Q26991958-B6B191BB-23CB-482F-AFD0-71F28C464807 Q27488883-7AD7B5C2-9FBC-4C31-BFEA-E93652A3CF79 Q27490328-5C4A2A50-1C60-4D35-8972-8542C7E7FD2C Q28540272-56DF84D7-EF46-402F-9D12-87F1BA813C80 Q28658980-E273C98B-6F83-4883-84E1-000C80E761D5 Q28674930-1355CAEC-D1FB-4B34-8AD6-7198317FACE4 Q30244921-E09A21A7-80FB-42C8-BA48-B264BEB1F183 Q30558355-CE62E741-358A-40A2-848A-12F465F52ADA Q33449162-F62CD564-FEB9-4ECC-9317-B9D929F2BABA Q33577551-3D5F7124-E21E-4177-9420-D6929E956FE5 Q33584149-3B83828F-C2B7-4F53-91F9-93862009E81A Q33626016-55555046-D631-444E-A5D6-5C00915E0E43 Q33680743-D17F90BD-F65D-4026-82AE-CE7976AB3BDC Q33737879-9BC44DB8-E9F9-4833-A125-5377A123270F Q33761406-42679471-EFEB-4ABC-9827-F60EF71E2E25 Q33812820-8310A55B-76CB-449E-B790-2F2764B1111E Q33904174-FCBECF39-ECFA-48D3-82F8-DD9718B3387D Q33907429-ECF70527-282A-41EA-84AB-20A9E89AFCF1 Q33924628-10D6A77E-9474-4AE1-AC48-BEB4C4DE6409 Q34042078-C3D622DF-C60A-413F-BD2F-A720F027D63B Q34070485-B97EF880-632A-4D38-9E68-5E8727920F82 Q34123580-EE7F4984-A471-42E1-8886-C5BA1A72907F Q34171589-E3C34A01-1673-4AB1-BE84-1094546DE2D2 Q34329530-12F186D1-D16C-4860-A9F6-6CF79339B3A9 Q34360320-5B8E35DD-50C0-48B4-8A84-D5CA13D41147 Q34368843-7074F091-A280-42BD-82E4-9AB106292458 Q34425509-742999F3-9EF1-4F54-91D2-EB0787F8B4FF Q34474989-ACC9DE68-036C-4B89-94FA-9013E7FC647D Q34505231-583BE846-0CB0-4014-9A00-54CE461655AA Q34561257-2A57CB4D-7D98-4433-A4CB-12FB7129C617 Q34677793-9F3503D4-1BFA-492F-A218-0D4770A82970 Q34764161-6A71D2EF-00EC-42C2-9F47-B4757B39A3AC Q34772738-9E73A8E0-9CE8-4D98-95C4-952F2DE99B63 Q34966832-4CCFB0AB-19F8-4701-BFBC-C4E853BEEBA7

P2860

Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

http://www.wikidata.org/entity/Q34775968

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@ast

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@en

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@nl

type

label

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@ast

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@en

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@nl

prefLabel

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@ast

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@en

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@nl

P1433

Q34775968-F72575B5-116F-420E-832A-BAEBFEB5F933

P1476

Q34775968-C84490B5-4E56-4C9B-94BF-74965569B2A7

P2093

Q34775968-0214A1E6-52AE-460A-B8BE-F4C06DBA3EDE

Q34775968-1C181241-6943-4598-B48D-D9AF74F0F5F9

Q34775968-20AC70A7-C5D1-4CE5-A524-DDCF75B35BC8

Q34775968-57DC006C-D0E1-44A2-B2B0-27F2C75B0BB2

Q34775968-7C25E12F-86F0-4F83-BB0F-19EED7759C86

Q34775968-8364FF40-D7DD-461B-9C3C-FC00AD2AE627

Q34775968-9230A284-7777-4ACA-B7E1-CE17557A00C9

Q34775968-9FC94867-7944-4C5F-9CF8-09A3A34C2A19

Q34775968-F106B3DF-CF4D-4858-BE83-3FC29F641E7F

Q34775968-F3168A74-47DD-4523-9F8B-322B72225135

P2860

Q34775968-01A0FF0A-61E1-4B0E-8105-DDEDA243AD00

Q34775968-0613597C-BBDB-4279-8379-2A1F4C314D63

Q34775968-0A73BC77-EE86-434A-A580-13BDD9A93811

Q34775968-0D011626-E093-45EA-86D7-32C35C48CB3A

Q34775968-128AC9BD-B2B8-4620-AA7A-CD52873FF052

Q34775968-25DF4E06-78B3-4836-BB4B-47CFFA55D4E0

Q34775968-354E42BD-449E-479A-A4E8-BCE678D45EFF

Q34775968-4495177E-717C-4194-9539-048C4DB34DB9

Q34775968-4930C9F9-0EDB-49BF-80B7-1F7487577F01

Q34775968-4ABED022-F393-4F60-9E3B-42B68F1BB0B5

P304

Q34775968-EFB98425-8B46-4F59-A73B-E552DB4780E2

P31

Q34775968-EE00F676-94B6-4519-AFF6-9B82A6F1AD7D

P356

Q34775968-A31F71B6-026E-47B7-B7D1-F6D919EF2987

P407

Q34775968-E8538CC7-3351-4941-96A5-EF5F8C45A0AC

P433

Q34775968-146B3448-62AE-4BAB-8027-855437EEC589

P478

Q34775968-5FEF43E7-3274-4217-BEBB-B5D1E7FD413F

P50

Q34775968-8B9DA6BD-EFC4-4B03-88F5-3034E7EEBAFD

P577

Q34775968-F614DCAC-E38B-4443-B97E-AEAD7E2F1E6B

P5875

Q34775968-E9E93A55-E130-46F6-A885-983602B716C5

P698

Q34775968-F560B2A4-2B69-4B86-A90E-069C0CD833E4

P932

Q34775968-B2117B60-BB84-4C5D-B184-C4EEE5D7B7F6

P356

J.GASTRO.2008.03.022

P1433

Gastroenterology

P1476

Human immunodeficiency virus-r ...... nd progression of hepatitis C.

@en

P2093

Anand Mehta

http://www.w3.org/2001/XMLSchema#string

Andrea L Cox

http://www.w3.org/2001/XMLSchema#string

Ashwin Balagopal

http://www.w3.org/2001/XMLSchema#string

David L Thomas

http://www.w3.org/2001/XMLSchema#string

Frances H Philp

http://www.w3.org/2001/XMLSchema#string

Gregory D Kirk

http://www.w3.org/2001/XMLSchema#string

Jacquie Astemborski

http://www.w3.org/2001/XMLSchema#string

Ronald Long

http://www.w3.org/2001/XMLSchema#string

Shruti H Mehta

http://www.w3.org/2001/XMLSchema#string

Timothy M Block

http://www.w3.org/2001/XMLSchema#string

P2860

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

TLR4 enhances TGF-beta signaling and hepatic fibrosis

Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes.

Humoral immune response in acute hepatitis C virus infection.

Alcohol use and hepatitis C.

The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.

Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection.

P304

226-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2008.03.022

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5394664

http://www.w3.org/2001/XMLSchema#string

P698

18457674

http://www.w3.org/2001/XMLSchema#string

P932

2644903

http://www.w3.org/2001/XMLSchema#string